GP PHARM
LIVE

Serial Number

79216752

Owner

GP Pharm S.A.

Attorney

Elizabeth Lee D'Amore

Filing Date

Apr 24, 2017

Add to watchlist:

No watchlists yet
View on USPTO

GP PHARM Trademark

Serial Number: 79216752 • Registration: 5435660

GP PHARM is a trademark filed by GP Pharm S.A. on April 24, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GP Pharm S.A.

PolĂ­gono Industrial Els.
Barcelona E-08777 , ES

Entity Type: 99

Trademark Details

Filing Date

April 24, 2017

Registration Date

April 3, 2018

Published for Opposition

January 16, 2018

Goods & Services

House mark for pharmaceutical preparations other than veterinary preparations; [ Sanitary products for medical purposes, namely, sterilizing preparations and antibacterial preparations; Dietetic substances for medical use, namely, dietetic foods adapted for medical use; Food for babies; Medical plasters, being material for dressings, namely, medical dressings, bandages, gauzes, adhesive bands, tapes; Material for dental fillings and dental impressions; Disinfectants; herbicides; ] pharmaceutical preparations and substances for use in urology, oncology and gynecology

Scientific and technological services, as well as research and design services relating thereto, namely, scientific research for medical purposes in the field of urology, oncology, gynecology, cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, anti-cancer treatments, chemotherapy, hormonal therapies, treatment of pain and inflammation, treatment of muscular disorders, treatment of metabolic disorders and active peptides for medical use; Pharmaceutical research services; Biological research and medical research; Clinical research in the field of urology, oncology, gynecology, cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, chemotherapy, hormonal therapies, analgesia, anti-inflammatory compounds, muscular disorders, metabolic disorders and active peptides for medical use

Chemicals used in the cosmetic and pharmaceutical industries for human use

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 5, 2026 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Jan 13, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 13, 2026 XXCR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 9, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2025 REAP
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 20, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 20, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Nov 20, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 18, 2024 APRE
TEAS SECTION 71 RECEIVED
Mar 27, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 3, 2023 REM3
CORRECTION UNDER SECTION 7 - PROCESSED
Feb 6, 2019 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 18, 2018 APRE
TEAS SECTION 7 REQUEST RECEIVED
Aug 29, 2018 ES7R
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 11, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 14, 2018 FICS
FINAL DISPOSITION PROCESSED
Jul 14, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 3, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Feb 3, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 27, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 27, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 9, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 9, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 9, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 9, 2017 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 9, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 21, 2017 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 8, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 8, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 8, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 8, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2017 CRFA
ASSIGNED TO LIE
Nov 1, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2017 TROA
REFUSAL PROCESSED BY IB
Oct 21, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 28, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 26, 2017 RFCR
APPLICATION FILING RECEIPT MAILED
Sep 26, 2017 MAFR
NON-FINAL ACTION WRITTEN
Sep 25, 2017 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 21, 2017 REPR